Janney Montgomery Scott LLC increased its position in Avanos Medical, Inc. (NYSE:AVNS – Free Report) by 194.3% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 35,918 shares of the company’s stock after purchasing an additional 23,714 shares during the quarter. Janney Montgomery Scott LLC owned approximately 0.08% of Avanos Medical worth $863,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. The Manufacturers Life Insurance Company raised its stake in shares of Avanos Medical by 3.6% during the second quarter. The Manufacturers Life Insurance Company now owns 17,137 shares of the company’s stock worth $341,000 after buying an additional 590 shares during the last quarter. New York State Teachers Retirement System grew its holdings in Avanos Medical by 2.0% during the 3rd quarter. New York State Teachers Retirement System now owns 72,294 shares of the company’s stock worth $1,737,000 after acquiring an additional 1,388 shares during the period. State Board of Administration of Florida Retirement System raised its position in shares of Avanos Medical by 8.6% during the 1st quarter. State Board of Administration of Florida Retirement System now owns 19,053 shares of the company’s stock valued at $379,000 after acquiring an additional 1,516 shares during the last quarter. Pitcairn Co. lifted its stake in shares of Avanos Medical by 11.2% in the 1st quarter. Pitcairn Co. now owns 15,940 shares of the company’s stock valued at $317,000 after purchasing an additional 1,606 shares during the period. Finally, Caxton Associates LP boosted its position in shares of Avanos Medical by 13.6% in the 2nd quarter. Caxton Associates LP now owns 17,035 shares of the company’s stock worth $339,000 after purchasing an additional 2,034 shares during the last quarter. 95.17% of the stock is owned by institutional investors.
Avanos Medical Price Performance
AVNS opened at $18.68 on Friday. Avanos Medical, Inc. has a 12 month low of $17.39 and a 12 month high of $25.36. The company has a quick ratio of 1.46, a current ratio of 2.22 and a debt-to-equity ratio of 0.12. The stock has a market cap of $858.53 million, a P/E ratio of 54.94 and a beta of 0.92. The company has a fifty day simple moving average of $22.30 and a 200 day simple moving average of $21.59.
Wall Street Analyst Weigh In
Read Our Latest Analysis on AVNS
Avanos Medical Profile
Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.
Read More
- Five stocks we like better than Avanos Medical
- Bank Stocks – Best Bank Stocks to Invest In
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- The Role Economic Reports Play in a Successful Investment Strategy
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- How to Invest in Blue Chip Stocks
- Time to Load Up on Home Builders?
Want to see what other hedge funds are holding AVNS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avanos Medical, Inc. (NYSE:AVNS – Free Report).
Receive News & Ratings for Avanos Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avanos Medical and related companies with MarketBeat.com's FREE daily email newsletter.